This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-181d-5p | ACSL1 | 0.15 | 0.888 | -0.05 | 0.97145 | MirTarget | -0.15 | 0.00429 | NA | |
2 | hsa-miR-191-5p | ACSL1 | -0.48 | 0.81535 | -0.05 | 0.97145 | miRNAWalker2 validate | -0.22 | 0.00167 | NA | |
3 | hsa-miR-192-5p | ACSL1 | -0.12 | 0.97293 | -0.05 | 0.97145 | miRNAWalker2 validate | -0.17 | 0.00124 | NA | |
4 | hsa-miR-335-5p | ACSL1 | -0.03 | 0.97338 | -0.05 | 0.97145 | miRNAWalker2 validate | -0.25 | 3.0E-5 | NA | |
5 | hsa-miR-454-3p | ACSL1 | -0.1 | 0.84355 | -0.05 | 0.97145 | MirTarget | -0.37 | 0 | NA | |
6 | hsa-miR-26b-3p | ACSL4 | -0.36 | 0.68112 | 0.11 | 0.93597 | MirTarget | -0.18 | 0.00094 | NA | |
7 | hsa-miR-26b-5p | ACSL4 | -0.02 | 0.99038 | 0.11 | 0.93597 | mirMAP | -0.25 | 0.00043 | NA | |
8 | hsa-miR-429 | ACSL4 | -0.46 | 0.80624 | 0.11 | 0.93597 | miRanda; miRNATAP | -0.14 | 0.00089 | NA | |
9 | hsa-miR-495-3p | ACSL4 | 0 | 0.99753 | 0.11 | 0.93597 | mirMAP | -0.19 | 0.00434 | NA | |
10 | hsa-miR-590-3p | ACSL4 | -0.28 | 0.59127 | 0.11 | 0.93597 | MirTarget; PITA; miRanda; mirMAP | -0.12 | 0.00663 | NA | |
11 | hsa-miR-7-1-3p | ACSL4 | -0.46 | 0.6659 | 0.11 | 0.93597 | mirMAP | -0.14 | 0.00889 | NA | |
12 | hsa-let-7b-5p | ACSL6 | -0.23 | 0.93895 | 0.56 | 0.53055 | miRNATAP | -0.95 | 0.00213 | NA | |
13 | hsa-miR-150-3p | ACSL6 | -0.29 | 0.51427 | 0.56 | 0.53055 | MirTarget; miRNATAP | -0.44 | 0.00158 | NA | |
14 | hsa-miR-155-5p | ACSL6 | -0.41 | 0.82867 | 0.56 | 0.53055 | mirMAP | -0.95 | 1.0E-5 | NA | |
15 | hsa-miR-27b-5p | ACSL6 | -0.33 | 0.68662 | 0.56 | 0.53055 | MirTarget | -1.52 | 0 | NA | |
16 | hsa-miR-582-5p | ACSL6 | -0.4 | 0.58123 | 0.56 | 0.53055 | mirMAP; miRNATAP | -0.82 | 0.00055 | NA | |
17 | hsa-miR-21-3p | ADIPOQ | -0.4 | 0.8782 | -0.07 | 0.95604 | MirTarget | -1.45 | 0 | NA | |
18 | hsa-miR-30b-3p | ADIPOQ | -0.51 | 0.16242 | -0.07 | 0.95604 | MirTarget | -0.69 | 0.00662 | NA | |
19 | hsa-miR-339-5p | ADIPOQ | -0.3 | 0.71291 | -0.07 | 0.95604 | miRanda | -0.65 | 0.0023 | NA | |
20 | hsa-miR-429 | ADIPOQ | -0.46 | 0.80624 | -0.07 | 0.95604 | miRanda | -1.39 | 0 | NA | |
21 | hsa-miR-491-3p | ADIPOQ | -0.51 | 0.13784 | -0.07 | 0.95604 | MirTarget | -0.7 | 0.00142 | NA | |
22 | hsa-miR-501-3p | ADIPOQ | -0.75 | 0.55276 | -0.07 | 0.95604 | MirTarget | -0.96 | 7.0E-5 | NA | |
23 | hsa-miR-502-3p | ADIPOQ | -0.48 | 0.5143 | -0.07 | 0.95604 | MirTarget | -1.04 | 0.00022 | NA | |
24 | hsa-miR-577 | ADIPOQ | -1.06 | 0.32606 | -0.07 | 0.95604 | mirMAP | -0.8 | 0 | NA | |
25 | hsa-miR-590-3p | ADIPOQ | -0.28 | 0.59127 | -0.07 | 0.95604 | PITA; miRanda; mirMAP | -1.02 | 0 | NA | |
26 | hsa-miR-940 | ADIPOQ | -0.23 | 0.68006 | -0.07 | 0.95604 | MirTarget | -0.75 | 5.0E-5 | NA | |
27 | hsa-miR-26b-5p | CD36 | -0.02 | 0.99038 | 0.68 | 0.31744 | miRNAWalker2 validate | -0.66 | 8.0E-5 | NA | |
28 | hsa-miR-335-5p | CD36 | -0.03 | 0.97338 | 0.68 | 0.31744 | miRNAWalker2 validate | -0.51 | 1.0E-5 | NA | |
29 | hsa-miR-362-3p | CD36 | -0.72 | 0.03459 | 0.68 | 0.31744 | miRanda | -0.36 | 0.00049 | NA | |
30 | hsa-miR-421 | CD36 | -0.18 | 0.7347 | 0.68 | 0.31744 | miRanda | -0.37 | 0.00244 | NA | |
31 | hsa-miR-590-3p | CD36 | -0.28 | 0.59127 | 0.68 | 0.31744 | miRanda | -0.52 | 0 | NA | |
32 | hsa-miR-629-3p | CD36 | -0.5 | 0.33397 | 0.68 | 0.31744 | MirTarget | -0.35 | 0.00045 | NA | |
33 | hsa-miR-96-5p | CD36 | 0.09 | 0.92309 | 0.68 | 0.31744 | MirTarget | -0.67 | 0 | NA | |
34 | hsa-miR-491-5p | CPT1C | -0.59 | 0.04526 | 0.64 | 0.07216 | miRanda | -0.22 | 0.00449 | NA | |
35 | hsa-miR-188-3p | FABP4 | -0.29 | 0.47502 | 1.24 | 0.11904 | MirTarget | -0.75 | 0 | NA | |
36 | hsa-miR-30c-1-3p | FABP4 | -0.2 | 0.51149 | 1.24 | 0.11904 | MirTarget | -0.93 | 0 | NA | |
37 | hsa-miR-335-5p | FABP4 | -0.03 | 0.97338 | 1.24 | 0.11904 | miRNAWalker2 validate | -0.87 | 0 | NA | |
38 | hsa-miR-361-5p | FABP4 | -0.14 | 0.9415 | 1.24 | 0.11904 | MirTarget; miRanda | -1.48 | 2.0E-5 | NA | |
39 | hsa-miR-455-3p | FABP4 | -0.36 | 0.82464 | 1.24 | 0.11904 | miRNATAP | -0.97 | 0 | NA | |
40 | hsa-miR-589-3p | FABP4 | -0.84 | 0.0112 | 1.24 | 0.11904 | MirTarget | -0.82 | 0 | NA | |
41 | hsa-miR-590-3p | FABP4 | -0.28 | 0.59127 | 1.24 | 0.11904 | miRanda | -1.03 | 0 | NA | |
42 | hsa-miR-26b-5p | FADS2 | -0.02 | 0.99038 | 0.51 | 0.6691 | miRNAWalker2 validate | -0.59 | 7.0E-5 | NA | |
43 | hsa-miR-335-5p | FADS2 | -0.03 | 0.97338 | 0.51 | 0.6691 | miRNAWalker2 validate | -0.59 | 0 | NA | |
44 | hsa-miR-361-5p | FADS2 | -0.14 | 0.9415 | 0.51 | 0.6691 | miRanda | -0.96 | 0 | NA | |
45 | hsa-miR-423-3p | FADS2 | -0.35 | 0.81316 | 0.51 | 0.6691 | miRNAWalker2 validate | -0.51 | 7.0E-5 | NA | |
46 | hsa-miR-500a-3p | FADS2 | -0.63 | 0.73258 | 0.51 | 0.6691 | miRNAWalker2 validate | -0.59 | 0 | NA | |
47 | hsa-miR-185-3p | ILK | 0.1 | 0.85691 | 0.13 | 0.93511 | MirTarget; miRNATAP | -0.15 | 0 | NA | |
48 | hsa-miR-222-3p | ILK | -0.03 | 0.98401 | 0.13 | 0.93511 | miRNAWalker2 validate | -0.1 | 0.00065 | NA | |
49 | hsa-miR-30c-1-3p | ILK | -0.2 | 0.51149 | 0.13 | 0.93511 | MirTarget | -0.12 | 0 | NA | |
50 | hsa-miR-335-3p | ILK | -0.24 | 0.8845 | 0.13 | 0.93511 | MirTarget | -0.16 | 0 | NA | |
51 | hsa-miR-361-3p | ILK | -0.29 | 0.84773 | 0.13 | 0.93511 | miRNATAP | -0.2 | 0 | NA | |
52 | hsa-miR-148b-3p | LPL | -0.2 | 0.91188 | 0.84 | 0.30981 | miRNAWalker2 validate | -0.53 | 0.00381 | NA | |
53 | hsa-miR-29b-3p | LPL | -0.1 | 0.95899 | 0.84 | 0.30981 | miRNATAP | -0.39 | 0.00181 | NA | |
54 | hsa-miR-590-3p | LPL | -0.28 | 0.59127 | 0.84 | 0.30981 | miRanda; mirMAP; miRNATAP | -0.39 | 0.00019 | NA | |
55 | hsa-miR-361-5p | MMP1 | -0.14 | 0.9415 | -0.33 | 0.81332 | miRanda | -0.99 | 0.00042 | NA | |
56 | hsa-miR-320a | OLR1 | -0.42 | 0.8402 | 0.49 | 0.44526 | miRanda | -0.7 | 2.0E-5 | NA | |
57 | hsa-miR-320b | OLR1 | -0.24 | 0.85922 | 0.49 | 0.44526 | miRanda | -0.51 | 0.00052 | NA | |
58 | hsa-miR-320c | OLR1 | -0.58 | 0.1136 | 0.49 | 0.44526 | miRanda | -0.32 | 0.0032 | NA | |
59 | hsa-miR-335-3p | OLR1 | -0.24 | 0.8845 | 0.49 | 0.44526 | mirMAP | -0.69 | 0 | NA | |
60 | hsa-miR-421 | OLR1 | -0.18 | 0.7347 | 0.49 | 0.44526 | miRanda | -0.51 | 0.0001 | NA | |
61 | hsa-miR-491-3p | OLR1 | -0.51 | 0.13784 | 0.49 | 0.44526 | MirTarget | -0.49 | 2.0E-5 | NA | |
62 | hsa-miR-501-3p | OLR1 | -0.75 | 0.55276 | 0.49 | 0.44526 | TargetScan | -0.44 | 0.00065 | NA | |
63 | hsa-miR-590-3p | OLR1 | -0.28 | 0.59127 | 0.49 | 0.44526 | miRanda; mirMAP | -0.63 | 0 | NA | |
64 | hsa-miR-590-5p | OLR1 | -0.55 | 0.47274 | 0.49 | 0.44526 | miRanda | -0.78 | 0 | NA | |
65 | hsa-miR-96-5p | OLR1 | 0.09 | 0.92309 | 0.49 | 0.44526 | MirTarget | -0.7 | 0 | NA | |
66 | hsa-miR-22-5p | PDPK1 | -0.08 | 0.9317 | -0 | 0.99893 | miRNATAP | -0.11 | 0.00108 | NA | |
67 | hsa-miR-942-5p | PLTP | -0.51 | 0.50778 | -0.1 | 0.9433 | MirTarget | -0.2 | 0.00917 | NA | |
68 | hsa-let-7i-5p | PPARA | -0.2 | 0.92202 | -0.15 | 0.91191 | miRNATAP | -0.35 | 0 | NA | |
69 | hsa-miR-146b-5p | PPARA | -0.4 | 0.83751 | -0.15 | 0.91191 | mirMAP | -0.16 | 0.00109 | NA | |
70 | hsa-miR-193b-5p | PPARA | 0.2 | 0.60647 | -0.15 | 0.91191 | mirMAP | -0.1 | 0.00932 | NA | |
71 | hsa-miR-218-5p | PPARA | 0.23 | 0.81021 | -0.15 | 0.91191 | mirMAP | -0.11 | 0.00341 | NA | |
72 | hsa-miR-369-3p | PPARA | 0.12 | 0.8323 | -0.15 | 0.91191 | mirMAP | -0.11 | 0.00834 | NA | |
73 | hsa-miR-382-5p | PPARA | 0.04 | 0.96032 | -0.15 | 0.91191 | mirMAP | -0.16 | 0.00169 | NA | |
74 | hsa-miR-455-5p | PPARA | -0.14 | 0.86574 | -0.15 | 0.91191 | miRanda | -0.11 | 0.00991 | NA | |
75 | hsa-miR-92a-3p | PPARD | 0.03 | 0.99325 | 0.1 | 0.93929 | miRNAWalker2 validate | -0.15 | 0.00019 | NA | |
76 | hsa-miR-511-5p | PPARG | -0.31 | 0.6072 | 0.06 | 0.96454 | MirTarget | -0.21 | 0.00019 | NA | |
77 | hsa-miR-30c-2-3p | RXRB | 0.24 | 0.74693 | 0.04 | 0.9769 | MirTarget | -0.14 | 0 | NA | |
78 | hsa-let-7g-3p | RXRG | -0.49 | 0.62942 | 0.29 | 0.79217 | MirTarget; miRNATAP | -0.46 | 0 | NA | |
79 | hsa-miR-23a-3p | RXRG | -0.12 | 0.96272 | 0.29 | 0.79217 | MirTarget | -0.69 | 0.00085 | NA | |
80 | hsa-miR-362-3p | RXRG | -0.72 | 0.03459 | 0.29 | 0.79217 | miRNATAP | -0.24 | 0.00785 | NA | |
81 | hsa-miR-141-3p | SCD5 | -0.32 | 0.87774 | -0.32 | 0.67415 | TargetScan | -0.3 | 0.00019 | NA | |
82 | hsa-miR-17-5p | SCD5 | -0.18 | 0.93454 | -0.32 | 0.67415 | TargetScan | -0.25 | 0.00271 | NA | |
83 | hsa-miR-30b-5p | SCD5 | -0.01 | 0.99462 | -0.32 | 0.67415 | mirMAP | -0.3 | 0.00167 | NA | |
84 | hsa-miR-339-5p | SCD5 | -0.3 | 0.71291 | -0.32 | 0.67415 | miRanda | -0.29 | 0.00024 | NA | |
85 | hsa-miR-362-3p | SCD5 | -0.72 | 0.03459 | -0.32 | 0.67415 | miRanda | -0.2 | 0.00924 | NA | |
86 | hsa-miR-374a-5p | SCD5 | -0.34 | 0.76692 | -0.32 | 0.67415 | MirTarget; mirMAP | -0.54 | 7.0E-5 | NA | |
87 | hsa-miR-374b-5p | SCD5 | -0.29 | 0.8357 | -0.32 | 0.67415 | MirTarget; mirMAP | -0.56 | 3.0E-5 | NA | |
88 | hsa-miR-590-5p | SCD5 | -0.55 | 0.47274 | -0.32 | 0.67415 | miRanda | -0.43 | 0 | NA | |
89 | hsa-miR-592 | SCD5 | -0.18 | 0.85623 | -0.32 | 0.67415 | MirTarget | -0.15 | 0.00012 | NA | |
90 | hsa-miR-34c-5p | SCP2 | -0.02 | 0.95279 | -0.19 | 0.90676 | miRanda | -0.12 | 0.0003 | NA | |
91 | hsa-miR-18a-5p | SLC27A1 | -0.5 | 0.61264 | -0.01 | 0.99455 | mirMAP | -0.18 | 5.0E-5 | NA | |
92 | hsa-miR-194-3p | SLC27A1 | -0.61 | 0.73321 | -0.01 | 0.99455 | MirTarget; mirMAP | -0.31 | 0 | NA | |
93 | hsa-miR-421 | SLC27A1 | -0.18 | 0.7347 | -0.01 | 0.99455 | miRanda; mirMAP | -0.28 | 0 | NA | |
94 | hsa-miR-940 | SLC27A1 | -0.23 | 0.68006 | -0.01 | 0.99455 | MirTarget | -0.18 | 4.0E-5 | NA | |
95 | hsa-let-7a-3p | SORBS1 | -0.22 | 0.85543 | 0.41 | 0.75061 | miRNATAP | -0.55 | 0 | NA | |
96 | hsa-let-7b-3p | SORBS1 | -0.29 | 0.81216 | 0.41 | 0.75061 | miRNATAP | -0.49 | 8.0E-5 | NA | |
97 | hsa-let-7g-3p | SORBS1 | -0.49 | 0.62942 | 0.41 | 0.75061 | miRNATAP | -0.44 | 0 | NA | |
98 | hsa-miR-142-5p | SORBS1 | -0.12 | 0.92967 | 0.41 | 0.75061 | PITA; miRNATAP | -0.38 | 0 | NA | |
99 | hsa-miR-146b-5p | SORBS1 | -0.4 | 0.83751 | 0.41 | 0.75061 | miRanda | -0.38 | 0.0002 | NA | |
100 | hsa-miR-186-5p | SORBS1 | -0.32 | 0.85413 | 0.41 | 0.75061 | mirMAP | -0.8 | 0 | NA | |
101 | hsa-miR-19b-1-5p | SORBS1 | -0.01 | 0.98851 | 0.41 | 0.75061 | mirMAP | -0.43 | 0 | NA | |
102 | hsa-miR-22-5p | SORBS1 | -0.08 | 0.9317 | 0.41 | 0.75061 | mirMAP | -0.36 | 2.0E-5 | NA | |
103 | hsa-miR-320a | SORBS1 | -0.42 | 0.8402 | 0.41 | 0.75061 | miRNAWalker2 validate; mirMAP | -0.4 | 0.00015 | NA | |
104 | hsa-miR-320b | SORBS1 | -0.24 | 0.85922 | 0.41 | 0.75061 | mirMAP | -0.32 | 0.0008 | NA | |
105 | hsa-miR-339-5p | SORBS1 | -0.3 | 0.71291 | 0.41 | 0.75061 | miRanda | -0.39 | 0 | NA | |
106 | hsa-miR-345-5p | SORBS1 | -0.72 | 0.40504 | 0.41 | 0.75061 | miRNATAP | -0.39 | 0 | NA | |
107 | hsa-miR-429 | SORBS1 | -0.46 | 0.80624 | 0.41 | 0.75061 | miRNATAP | -0.48 | 0 | NA | |
108 | hsa-miR-539-5p | SORBS1 | 0.12 | 0.80107 | 0.41 | 0.75061 | mirMAP | -0.35 | 0.00041 | NA | |
109 | hsa-miR-577 | SORBS1 | -1.06 | 0.32606 | 0.41 | 0.75061 | miRNATAP | -0.33 | 0 | NA | |
110 | hsa-miR-582-5p | SORBS1 | -0.4 | 0.58123 | 0.41 | 0.75061 | miRNATAP | -0.59 | 0 | NA | |
111 | hsa-miR-584-5p | SORBS1 | -0.22 | 0.90686 | 0.41 | 0.75061 | mirMAP | -0.29 | 0 | NA | |
112 | hsa-miR-590-3p | SORBS1 | -0.28 | 0.59127 | 0.41 | 0.75061 | miRanda | -0.55 | 0 | NA | |
113 | hsa-miR-590-5p | SORBS1 | -0.55 | 0.47274 | 0.41 | 0.75061 | miRanda | -0.55 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | FATTY ACID METABOLIC PROCESS | 13 | 296 | 1.259e-18 | 5.858e-15 |
2 | MONOCARBOXYLIC ACID METABOLIC PROCESS | 13 | 503 | 1.257e-15 | 2.924e-12 |
3 | LIPID METABOLIC PROCESS | 16 | 1158 | 2.408e-15 | 3.735e-12 |
4 | CELLULAR LIPID METABOLIC PROCESS | 14 | 913 | 8.619e-14 | 1.003e-10 |
5 | FATTY ACID TRANSPORT | 7 | 56 | 2.165e-13 | 2.015e-10 |
6 | ORGANIC ACID METABOLIC PROCESS | 13 | 953 | 4.421e-12 | 3.428e-09 |
7 | HORMONE MEDIATED SIGNALING PATHWAY | 8 | 158 | 5.627e-12 | 3.741e-09 |
8 | LIPID LOCALIZATION | 9 | 264 | 7.383e-12 | 4.294e-09 |
9 | MONOCARBOXYLIC ACID TRANSPORT | 7 | 124 | 6.701e-11 | 3.464e-08 |
10 | REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 5 | 28 | 1.22e-10 | 5.674e-08 |
11 | CELLULAR RESPONSE TO HORMONE STIMULUS | 10 | 552 | 1.96e-10 | 8.289e-08 |
12 | LONG CHAIN FATTY ACID METABOLIC PROCESS | 6 | 88 | 5.801e-10 | 2.249e-07 |
13 | SMALL MOLECULE METABOLIC PROCESS | 14 | 1767 | 6.389e-10 | 2.287e-07 |
14 | REGULATION OF LIPID TRANSPORT | 6 | 95 | 9.256e-10 | 2.927e-07 |
15 | REGULATION OF CHOLESTEROL STORAGE | 4 | 13 | 9.435e-10 | 2.927e-07 |
16 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 11 | 1008 | 3.905e-09 | 1.136e-06 |
17 | ORGANIC ANION TRANSPORT | 8 | 387 | 6.955e-09 | 1.904e-06 |
18 | ORGANIC ACID TRANSPORT | 7 | 261 | 1.22e-08 | 3.154e-06 |
19 | CELLULAR LIPID CATABOLIC PROCESS | 6 | 151 | 1.522e-08 | 3.541e-06 |
20 | LIPID OXIDATION | 5 | 70 | 1.455e-08 | 3.541e-06 |
21 | RESPONSE TO HORMONE | 10 | 893 | 2.017e-08 | 4.469e-06 |
22 | ANION TRANSPORT | 8 | 507 | 5.661e-08 | 1.197e-05 |
23 | NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 4 | 36 | 7.638e-08 | 1.545e-05 |
24 | RESPONSE TO INSULIN | 6 | 205 | 9.408e-08 | 1.647e-05 |
25 | REGULATION OF STEROL TRANSPORT | 4 | 38 | 9.557e-08 | 1.647e-05 |
26 | LIPID BIOSYNTHETIC PROCESS | 8 | 539 | 9.068e-08 | 1.647e-05 |
27 | REGULATION OF CHOLESTEROL TRANSPORT | 4 | 38 | 9.557e-08 | 1.647e-05 |
28 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 11 | 1381 | 1.019e-07 | 1.694e-05 |
29 | REGULATION OF LIPID STORAGE | 4 | 41 | 1.308e-07 | 2.099e-05 |
30 | LONG CHAIN FATTY ACID TRANSPORT | 4 | 42 | 1.445e-07 | 2.241e-05 |
31 | RESPONSE TO ENDOGENOUS STIMULUS | 11 | 1450 | 1.677e-07 | 2.517e-05 |
32 | REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 4 | 45 | 1.919e-07 | 2.79e-05 |
33 | REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 3 | 12 | 2.903e-07 | 3.752e-05 |
34 | REGULATION OF RESPONSE TO WOUNDING | 7 | 413 | 2.804e-07 | 3.752e-05 |
35 | STEROID HORMONE MEDIATED SIGNALING PATHWAY | 5 | 125 | 2.706e-07 | 3.752e-05 |
36 | LIPID CATABOLIC PROCESS | 6 | 247 | 2.827e-07 | 3.752e-05 |
37 | FATTY ACID BETA OXIDATION | 4 | 51 | 3.204e-07 | 3.822e-05 |
38 | FATTY ACYL COA METABOLIC PROCESS | 4 | 51 | 3.204e-07 | 3.822e-05 |
39 | POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 5 | 128 | 3.045e-07 | 3.822e-05 |
40 | ALPHA LINOLENIC ACID METABOLIC PROCESS | 3 | 13 | 3.771e-07 | 4.28e-05 |
41 | NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 3 | 13 | 3.771e-07 | 4.28e-05 |
42 | ACYL COA BIOSYNTHETIC PROCESS | 4 | 54 | 4.045e-07 | 4.377e-05 |
43 | THIOESTER BIOSYNTHETIC PROCESS | 4 | 54 | 4.045e-07 | 4.377e-05 |
44 | POSITIVE REGULATION OF TRANSPORT | 9 | 936 | 4.678e-07 | 4.947e-05 |
45 | REGULATION OF LIPID METABOLIC PROCESS | 6 | 282 | 6.148e-07 | 6.357e-05 |
46 | NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 3 | 16 | 7.367e-07 | 7.314e-05 |
47 | TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER | 5 | 153 | 7.388e-07 | 7.314e-05 |
48 | REGULATION OF INFLAMMATORY RESPONSE | 6 | 294 | 7.843e-07 | 7.603e-05 |
49 | POSITIVE REGULATION OF STEROL TRANSPORT | 3 | 17 | 8.939e-07 | 8.319e-05 |
50 | POSITIVE REGULATION OF CHOLESTEROL TRANSPORT | 3 | 17 | 8.939e-07 | 8.319e-05 |
51 | INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 5 | 168 | 1.173e-06 | 0.000107 |
52 | REGULATION OF DEFENSE RESPONSE | 8 | 759 | 1.225e-06 | 0.0001096 |
53 | FATTY ACID CATABOLIC PROCESS | 4 | 73 | 1.372e-06 | 0.0001205 |
54 | REGULATION OF TRANSPORT | 11 | 1804 | 1.516e-06 | 0.0001306 |
55 | REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS | 3 | 21 | 1.743e-06 | 0.0001475 |
56 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 11 | 1848 | 1.926e-06 | 0.00016 |
57 | THIOESTER METABOLIC PROCESS | 4 | 83 | 2.299e-06 | 0.0001783 |
58 | RESPONSE TO FATTY ACID | 4 | 83 | 2.299e-06 | 0.0001783 |
59 | ACYL COA METABOLIC PROCESS | 4 | 83 | 2.299e-06 | 0.0001783 |
60 | RESPONSE TO NUTRIENT | 5 | 191 | 2.206e-06 | 0.0001783 |
61 | NEUTRAL LIPID METABOLIC PROCESS | 4 | 85 | 2.529e-06 | 0.0001929 |
62 | DNA TEMPLATED TRANSCRIPTION INITIATION | 5 | 202 | 2.903e-06 | 0.0002178 |
63 | LIPID MODIFICATION | 5 | 210 | 3.51e-06 | 0.0002593 |
64 | RESPONSE TO LIPID | 8 | 888 | 3.956e-06 | 0.0002876 |
65 | MONOCARBOXYLIC ACID CATABOLIC PROCESS | 4 | 96 | 4.115e-06 | 0.0002946 |
66 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 5 | 218 | 4.214e-06 | 0.0002971 |
67 | NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 4 | 100 | 4.843e-06 | 0.0003314 |
68 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 4 | 100 | 4.843e-06 | 0.0003314 |
69 | RESPONSE TO PEPTIDE | 6 | 404 | 4.939e-06 | 0.000333 |
70 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 8 | 917 | 5.02e-06 | 0.0003337 |
71 | UNSATURATED FATTY ACID METABOLIC PROCESS | 4 | 109 | 6.824e-06 | 0.0004472 |
72 | POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 3 | 33 | 7.087e-06 | 0.000458 |
73 | RESPONSE TO EXTRACELLULAR STIMULUS | 6 | 441 | 8.156e-06 | 0.0005198 |
74 | SMALL MOLECULE BIOSYNTHETIC PROCESS | 6 | 443 | 8.369e-06 | 0.0005262 |
75 | SINGLE ORGANISM BIOSYNTHETIC PROCESS | 9 | 1340 | 9.161e-06 | 0.0005684 |
76 | CELLULAR RESPONSE TO LIPID | 6 | 457 | 9.993e-06 | 0.0006118 |
77 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 6 | 465 | 1.103e-05 | 0.0006666 |
78 | COENZYME BIOSYNTHETIC PROCESS | 4 | 127 | 1.25e-05 | 0.0007459 |
79 | RESPONSE TO COLD | 3 | 43 | 1.591e-05 | 0.0009361 |
80 | RESPONSE TO STEROID HORMONE | 6 | 497 | 1.609e-05 | 0.0009361 |
81 | NEGATIVE REGULATION OF DEFENSE RESPONSE | 4 | 144 | 2.052e-05 | 0.001179 |
82 | CELLULAR RESPONSE TO INSULIN STIMULUS | 4 | 146 | 2.166e-05 | 0.001229 |
83 | REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 3 | 49 | 2.365e-05 | 0.001326 |
84 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 6 | 541 | 2.598e-05 | 0.001422 |
85 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 6 | 541 | 2.598e-05 | 0.001422 |
86 | POSITIVE REGULATION OF LIPID TRANSPORT | 3 | 51 | 2.669e-05 | 0.001444 |
87 | NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 4 | 156 | 2.81e-05 | 0.001503 |
88 | POSITIVE REGULATION OF RESPONSE TO WOUNDING | 4 | 162 | 3.257e-05 | 0.001722 |
89 | CELL SUBSTRATE ADHESION | 4 | 164 | 3.417e-05 | 0.001787 |
90 | COFACTOR BIOSYNTHETIC PROCESS | 4 | 166 | 3.583e-05 | 0.001853 |
91 | MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 4 | 172 | 4.117e-05 | 0.002105 |
92 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 5 | 351 | 4.197e-05 | 0.002123 |
93 | GLYCEROLIPID METABOLIC PROCESS | 5 | 356 | 4.49e-05 | 0.002246 |
94 | OXIDATION REDUCTION PROCESS | 7 | 898 | 4.681e-05 | 0.002317 |
95 | ION TRANSPORT | 8 | 1262 | 5.127e-05 | 0.002485 |
96 | CIRCULATORY SYSTEM PROCESS | 5 | 366 | 5.122e-05 | 0.002485 |
97 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 7 | 926 | 5.692e-05 | 0.00273 |
98 | REGULATION OF PHAGOCYTOSIS | 3 | 68 | 6.341e-05 | 0.003011 |
99 | REGULATION OF TRANSFERASE ACTIVITY | 7 | 946 | 6.518e-05 | 0.003064 |
100 | POSITIVE REGULATION OF MEMBRANE INVAGINATION | 2 | 11 | 6.914e-05 | 0.003154 |
101 | LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 2 | 11 | 6.914e-05 | 0.003154 |
102 | POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT | 2 | 11 | 6.914e-05 | 0.003154 |
103 | SINGLE ORGANISM CATABOLIC PROCESS | 7 | 957 | 7.014e-05 | 0.003168 |
104 | SULFUR COMPOUND BIOSYNTHETIC PROCESS | 4 | 203 | 7.843e-05 | 0.003509 |
105 | CARBOXYLIC ACID CATABOLIC PROCESS | 4 | 205 | 8.147e-05 | 0.003576 |
106 | ORGANIC ACID CATABOLIC PROCESS | 4 | 205 | 8.147e-05 | 0.003576 |
107 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 2 | 12 | 8.291e-05 | 0.003605 |
108 | WHITE FAT CELL DIFFERENTIATION | 2 | 13 | 9.792e-05 | 0.004032 |
109 | LIPOPROTEIN TRANSPORT | 2 | 13 | 9.792e-05 | 0.004032 |
110 | REGULATION OF PHAGOCYTOSIS ENGULFMENT | 2 | 13 | 9.792e-05 | 0.004032 |
111 | LIPOPROTEIN LOCALIZATION | 2 | 13 | 9.792e-05 | 0.004032 |
112 | NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS | 2 | 13 | 9.792e-05 | 0.004032 |
113 | REGULATION OF MEMBRANE INVAGINATION | 2 | 13 | 9.792e-05 | 0.004032 |
114 | NEGATIVE REGULATION OF PHOSPHORYLATION | 5 | 422 | 0.0001004 | 0.004098 |
115 | RESPONSE TO ABIOTIC STIMULUS | 7 | 1024 | 0.0001075 | 0.004348 |
116 | POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 2 | 14 | 0.0001142 | 0.004464 |
117 | RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE | 2 | 14 | 0.0001142 | 0.004464 |
118 | POSITIVE REGULATION OF FATTY ACID OXIDATION | 2 | 14 | 0.0001142 | 0.004464 |
119 | LINOLEIC ACID METABOLIC PROCESS | 2 | 14 | 0.0001142 | 0.004464 |
120 | POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 2 | 15 | 0.0001316 | 0.005042 |
121 | REGULATION OF FATTY ACID METABOLIC PROCESS | 3 | 87 | 0.0001322 | 0.005042 |
122 | REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 3 | 87 | 0.0001322 | 0.005042 |
123 | REGULATION OF RESPONSE TO STRESS | 8 | 1468 | 0.0001492 | 0.005645 |
124 | WOUND HEALING | 5 | 470 | 0.0001663 | 0.006238 |
125 | NEGATIVE REGULATION OF LIPID STORAGE | 2 | 17 | 0.0001703 | 0.006238 |
126 | REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 2 | 17 | 0.0001703 | 0.006238 |
127 | NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 2 | 17 | 0.0001703 | 0.006238 |
128 | NEGATIVE REGULATION OF KINASE ACTIVITY | 4 | 250 | 0.000175 | 0.006363 |
129 | POSITIVE REGULATION OF KINASE ACTIVITY | 5 | 482 | 0.0001871 | 0.006696 |
130 | ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 5 | 482 | 0.0001871 | 0.006696 |
131 | REGULATION OF KINASE ACTIVITY | 6 | 776 | 0.0001917 | 0.006757 |
132 | RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 2 | 18 | 0.0001914 | 0.006757 |
133 | FIBRIL ORGANIZATION | 2 | 19 | 0.0002138 | 0.007479 |
134 | COENZYME METABOLIC PROCESS | 4 | 265 | 0.0002188 | 0.007597 |
135 | CARBOXYLIC ACID BIOSYNTHETIC PROCESS | 4 | 270 | 0.000235 | 0.007669 |
136 | REGULATION OF FAT CELL DIFFERENTIATION | 3 | 106 | 0.0002372 | 0.007669 |
137 | REGULATION OF CHOLESTEROL EFFLUX | 2 | 20 | 0.0002374 | 0.007669 |
138 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 6 | 799 | 0.0002246 | 0.007669 |
139 | ORGANIC ACID BIOSYNTHETIC PROCESS | 4 | 270 | 0.000235 | 0.007669 |
140 | REGULATION OF GLUCOSE METABOLIC PROCESS | 3 | 106 | 0.0002372 | 0.007669 |
141 | RESPONSE TO VITAMIN A | 2 | 20 | 0.0002374 | 0.007669 |
142 | FAT CELL DIFFERENTIATION | 3 | 106 | 0.0002372 | 0.007669 |
143 | RESPONSE TO LIPOPROTEIN PARTICLE | 2 | 20 | 0.0002374 | 0.007669 |
144 | POSITIVE REGULATION OF LIPID STORAGE | 2 | 20 | 0.0002374 | 0.007669 |
145 | CELLULAR RESPONSE TO PEPTIDE | 4 | 274 | 0.0002485 | 0.00792 |
146 | NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 4 | 274 | 0.0002485 | 0.00792 |
147 | LIPID HOMEOSTASIS | 3 | 110 | 0.0002646 | 0.008208 |
148 | PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 2 | 21 | 0.0002622 | 0.008208 |
149 | TRIGLYCERIDE CATABOLIC PROCESS | 2 | 21 | 0.0002622 | 0.008208 |
150 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 6 | 823 | 0.0002637 | 0.008208 |
151 | CELL MOTILITY | 6 | 835 | 0.0002851 | 0.008728 |
152 | LOCALIZATION OF CELL | 6 | 835 | 0.0002851 | 0.008728 |
153 | REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 2 | 22 | 0.0002882 | 0.008764 |
154 | FATTY ACID BIOSYNTHETIC PROCESS | 3 | 114 | 0.0002939 | 0.008824 |
155 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 8 | 1618 | 0.0002929 | 0.008824 |
156 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 4 | 289 | 0.0003044 | 0.00908 |
157 | RESPONSE TO NITROGEN COMPOUND | 6 | 859 | 0.0003321 | 0.009815 |
158 | FOCAL ADHESION ASSEMBLY | 2 | 24 | 0.0003438 | 0.009815 |
159 | CELL MATRIX ADHESION | 3 | 119 | 0.0003334 | 0.009815 |
160 | MACROMOLECULAR COMPLEX REMODELING | 2 | 24 | 0.0003438 | 0.009815 |
161 | CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY | 2 | 24 | 0.0003438 | 0.009815 |
162 | PLASMA LIPOPROTEIN PARTICLE REMODELING | 2 | 24 | 0.0003438 | 0.009815 |
163 | PROTEIN LIPID COMPLEX REMODELING | 2 | 24 | 0.0003438 | 0.009815 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING | 5 | 48 | 2.093e-09 | 7.42e-07 |
2 | LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 4 | 13 | 9.435e-10 | 7.42e-07 |
3 | FATTY ACID LIGASE ACTIVITY | 4 | 16 | 2.396e-09 | 7.42e-07 |
4 | STEROID HORMONE RECEPTOR ACTIVITY | 5 | 59 | 6.069e-09 | 1.41e-06 |
5 | FATTY ACID BINDING | 4 | 31 | 4.096e-08 | 7.61e-06 |
6 | LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 4 | 40 | 1.181e-07 | 1.829e-05 |
7 | LIPID BINDING | 8 | 657 | 4.116e-07 | 5.463e-05 |
8 | LONG CHAIN FATTY ACID BINDING | 3 | 14 | 4.796e-07 | 5.569e-05 |
9 | MONOCARBOXYLIC ACID BINDING | 4 | 65 | 8.588e-07 | 8.864e-05 |
10 | ORGANIC ACID BINDING | 5 | 209 | 3.429e-06 | 0.0003186 |
11 | LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 2 | 13 | 9.792e-05 | 0.00827 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | MICROBODY PART | 4 | 93 | 3.625e-06 | 0.002117 |
2 | MICROBODY | 4 | 134 | 1.545e-05 | 0.004513 |
3 | MICROBODY MEMBRANE | 3 | 58 | 3.933e-05 | 0.007657 |
4 | OUTER MEMBRANE | 4 | 190 | 6.066e-05 | 0.008857 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa03320_PPAR_signaling_pathway | 23 | 70 | 5.592e-59 | 1.007e-56 | |
2 | hsa04920_Adipocytokine_signaling_pathway | 9 | 68 | 2.755e-17 | 2.479e-15 | |
3 | hsa00071_Fatty_acid_metabolism | 4 | 43 | 1.592e-07 | 9.551e-06 | |
4 | hsa04146_Peroxisome | 4 | 79 | 1.886e-06 | 8.485e-05 | |
5 | hsa01040_Biosynthesis_of_unsaturated_fatty_acids | 2 | 21 | 0.0002622 | 0.009438 | |
6 | hsa04910_Insulin_signaling_pathway | 2 | 138 | 0.01088 | 0.3263 | |
7 | hsa04145_Phagosome | 2 | 156 | 0.01374 | 0.3532 | |
8 | hsa04510_Focal_adhesion | 2 | 200 | 0.02193 | 0.4097 |